Literature DB >> 10740983

Novel antipsychotics and the neuropsychological deficiencies of schizophrenia.

K A Hawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10740983      PMCID： PMC1408046     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  11 in total

Review 1.  Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?

Authors:  K A Hawkins; S Mohamed; S W Woods
Journal:  Psychol Med       Date:  1999-01       Impact factor: 7.723

Review 2.  Dimensions of outcome with clozapine.

Authors:  H Y Meltzer
Journal:  Br J Psychiatry Suppl       Date:  1992-05

3.  Commentary on the clozapine conflict.

Authors:  J M Kane
Journal:  Am J Psychiatry       Date:  1996-11       Impact factor: 18.112

4.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  The role of neurocognitive deficits in understanding adaptive functioning in severe psychiatric illness: commentary on Hawkins and Cooper.

Authors:  K H Nuechterlein; K L Subotnik
Journal:  Psychiatry       Date:  1996       Impact factor: 2.458

6.  A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.

Authors:  H J Möller; H Müller; R L Borison; N R Schooler; G Chouinard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 7.  Patient response and resource management: another view of clozapine treatment of schizophrenia.

Authors:  W T Carpenter; R R Conley; R W Buchanan; A Breier; C A Tamminga
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

8.  Clozapine's effect on negative symptoms in treatment-refractory schizophrenics.

Authors:  D D Miller; P J Perry; R J Cadoret; N C Andreasen
Journal:  Compr Psychiatry       Date:  1994 Jan-Feb       Impact factor: 3.735

9.  Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].

Authors:  T H Svensson; J M Mathé; J L Andersson; G G Nomikos; B E Hildebrand; M Marcus
Journal:  J Clin Psychopharmacol       Date:  1995-02       Impact factor: 3.153

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112
View more
  1 in total

Review 1.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.